BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 1959705)

  • 1. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
    Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.
    Kawasaki E; Moriuchi R; Takino H; Okuno S; Takao Y; Maeda Y; Yokota A; Yamamoto H; Chikuba N; Akazawa S
    Diabetologia; 1992 Aug; 35(8):748-52. PubMed ID: 1511801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.
    Landin-Olsson M; Palmer JP; Lernmark A; Blom L; Sundkvist G; Nyström L; Dahlquist G
    Diabetologia; 1992 Nov; 35(11):1068-73. PubMed ID: 1473617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
    Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
    Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen.
    Baekkeskov S; Warnock G; Christie M; Rajotte RV; Larsen PM; Fey S
    Diabetes; 1989 Sep; 38(9):1133-41. PubMed ID: 2670643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.
    Petersen JS; Kyvik KO; Bingley PJ; Gale EA; Green A; Dyrberg T; Beck-Nielsen H
    BMJ; 1997 May; 314(7094):1575-9. PubMed ID: 9169400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
    Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
    Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell antibodies in normal French schoolchildren.
    Lévy-Marchal C; Tichet J; Fajardy I; Gu XF; Dubois F; Czernichow P
    Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.